4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-21-056530
Chief Corp. Affairs Officer sold 16,824 shares at $16.49 ($277,394)
- Chief Corp. Affairs Officer acquired 12,119 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jones Aranthan II Chief Corp. Affairs Officer | 2021-09-15 | Option exercise | +4,277 | $12.27 | $52,479 | 90,962 | D |
| Jones Aranthan II Chief Corp. Affairs Officer | 2021-09-15 | Option exercise | +7,842 | $11.32 | $88,771 | 98,804 | D |
| Jones Aranthan II Chief Corp. Affairs Officer | 2021-09-15 | Sale | −16,824 | $16.49 | $277,394 | 81,980 | D |
| Derivatives | |||||||
| Jones Aranthan II Chief Corp. Affairs Officer | 2021-09-15 | Option exercise · Employee Stock Option (Right to Buy) | −4,277 | 33,224 | D | ||
| Jones Aranthan II Chief Corp. Affairs Officer | 2021-09-15 | Option exercise · Employee Stock Option (Right to Buy) | −7,842 | 47,158 | D | ||
| Open-market sales · 16,824 sh · avg $16.49 · $277,394 | |||||||
Loading xslF345X03/doc4.xml…